Molecular Mechanisms of Drugs for Neuropsychiatric Disorders

Prof. Moshe Rehavi, Ph.D.
Department of Physiology and Pharmacology

Main projects in the lab include:

  1. Presynaptic monoamine transportes and the vesicular monoamine transporter as targets for neuropsychiatric drugs.
  2. Anxiolytic effects of new herbal treatment: mice models of anxiety and biochemical studies.
  3. Quaternary serotonin-reuptake inhibitors as novel anti-platelet drugs.
  4. Methylphenidate (Ritalin): abuse potential and long-term effects.
  5. Neuronal rescue by Rasagiline (MAO-B inhibitor) in thiamine deficiency.

 

Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
Developed by
UI/UX Basch_Interactive